Ramesh Srinivasan - 28 May 2024 Form 4 Insider Report for AGILYSYS INC (AGYS)

Role
President & CEO, Director
Signature
/s/ Kyle C. Badger, Attorney-in-Fact
Issuer symbol
AGYS
Transactions as of
28 May 2024
Net transactions value
-$9,580,000
Form type
4
Filing time
31 May 2024, 17:50:03 UTC
Previous filing
24 May 2024
Next filing
04 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGYS Common Stock Options Exercise $0 +600,000 +92% $0.000000 1,249,158 28 May 2024 Direct
transaction AGYS Common Stock Tax liability $0 -210,791 -17% $0.000000 1,038,367 28 May 2024 Direct
transaction AGYS Common Stock Sale $4,825,000 -50,000 -4.8% $96.50 988,367 29 May 2024 Direct F1
transaction AGYS Common Stock Sale $4,755,000 -50,000 -5.1% $95.10 938,367 30 May 2024 Direct F2
holding AGYS Common Stock 60,000 28 May 2024 By Ramesh and Sujatha Srinivasan Living Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGYS Stock-settled Appreciation Rights Options Exercise $0 -600,000 -100% $0.000000* 0 28 May 2024 Common Stock 600,000 $36.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.68 to $100.08. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.82 to $96.88. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F3 Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche.